Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Triple Negative Breast Cancer”

140 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 140 results

Testing effectiveness (Phase 2)Study completedNCT03154749
What this trial is testing

DCb (Docetaxel/Carboplatin) Versus EC-D (Epirubicin/Cyclophosphamide Followed by Docetaxe) as Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer
Guangdong Provincial People's Hospital 93
Testing effectiveness (Phase 2)Study completedNCT02301988
What this trial is testing

Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Genentech, Inc. 151
Large-scale testing (Phase 3)UnknownNCT02441933
What this trial is testing

Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)

Who this might be right for
Breast Cancer
Yonsei University 878
Not applicableNot Yet RecruitingNCT07478705
What this trial is testing

Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging

Who this might be right for
Triple Negative Breast CancerSurveillanceRecurrence+1 more
Sunnybrook Health Sciences Centre 30
Testing effectiveness (Phase 2)Looking for participantsNCT06225284
What this trial is testing

Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients

Who this might be right for
Triple Negative Breast CancerPremenopausal Breast Cancer
National Taiwan University Hospital 124
Testing effectiveness (Phase 2)Active Not RecruitingNCT02750358
What this trial is testing

Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer

Who this might be right for
Breast CancerEarly StageTriple Negative Breast Cancer
Memorial Sloan Kettering Cancer Center 50
Early research (Phase 1)Study completedNCT01576666
What this trial is testing

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Who this might be right for
Dose EscalationSafetyPreliminary Efficacy+9 more
Novartis Pharmaceuticals 120
Large-scale testing (Phase 3)Study completedNCT02032277
What this trial is testing

A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
AbbVie 634
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06371807
What this trial is testing

Trial for Treatment of High Risk BC With Two Sequences of Neoadjuvant Chemotherapy With Pembrolizumab

Who this might be right for
Early Breast CancerTriple Negative Breast Cancer
Fundacao Champalimaud 20
Not applicableLooking for participantsNCT06894173
What this trial is testing

EvoLution of Neoadjuvant TreatMent in 'Triple-negative' or 'HER-2-positive' Breast Cancer Diagnosed in the EaRly Phase

Who this might be right for
Breast Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,000
Not applicableNot Yet RecruitingNCT07491822
What this trial is testing

A Single-Arm, Single-Center, Phase II Clinical Study of Camrelizumab Combined With Radiochemotherapy as Neoadjuvant Therapy for Early-Stage Triple-Negative Breast Cancer

Who this might be right for
TNBC
Tianjin Medical University Cancer Institute and Hospital 43
Large-scale testing (Phase 3)Looking for participantsNCT06313463
What this trial is testing

Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapy

Who this might be right for
Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 375
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06787339
What this trial is testing

Capecitabine in Low Risk Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Fudan University 198
Not applicableNot Yet RecruitingNCT07597642
What this trial is testing

ON-treatment Single-cell Analysis for the Identification of Early Tumor Response Biomarkers on Prospective Collected Serial Tumor Biopsies in Triple Negative Breast Cancer Patient During Standard Neoadjuvant Chemo-immunotherapy

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
IRCCS San Raffaele 55
Very early researchUnknownNCT05680662
What this trial is testing

The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism

Who this might be right for
Breast Cancer FemaleTriple Negative Breast Cancer
Ministry of Health, Saudi Arabia 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07372079
What this trial is testing

Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy

Who this might be right for
Breast CancerNeoadjuvant TherapyImmune Checkpoint Inhibitors+1 more
Tianjin Medical University Cancer Institute and Hospital 40
Not applicableUnknownNCT04582955
What this trial is testing

Neoadjuvant Treatment of Early Triple-negative Breast Cancer With Chidamide and Chemotherapy

Who this might be right for
Triple-negative Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05382299
What this trial is testing

Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerPD-L1 Negative
Gilead Sciences 623
Testing effectiveness (Phase 2)Looking for participantsNCT06992336
What this trial is testing

Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 411
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06819319
What this trial is testing

SHR-A2102 Combined With Adebrelimab as Neoadjuvant Therapy for Early Triple-Negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Henan Cancer Hospital 52
Next Page